Vertex Pharmaceuticals (VRTX) recently announced strong financial results with Q2 2025 revenue increasing to $2,965 million from $2,646 million in Q2 2024, and net income turning positive. Despite ...

The drugmaker shed billions of dollars in value after it told investors that widening Journavx’s approval to chronic pain ...

Johnson & Johnson Vision professional affairs consultant, Nadia Siddiqi, outlines key considerations for locums when fitting ...

Procter & Gamble, based in Cincinnati, said Jejurikar, its current Chief Operating Officer, would replace Jon Moeller as CEO.

Jejurikar, who joined P&G as an assistant brand manager in 1989, will replace Jon Moeller as part of a top leadership transition ...